Mirum Pharmaceuticals, Inc. MIRM Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s common stock, shares issued (in shares)?
- Mirum Pharmaceuticals, Inc. (MIRM) reported common stock, shares issued (in shares) of $60.93M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s common stock, shares issued (in shares) increased by 23.2% year-over-year, from $49.45M to $60.93M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s common stock, shares issued (in shares)?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s common stock, shares issued (in shares) has grown at a 5.4% compound annual growth rate (CAGR), from $46.72M to $51.9M.